Global STD Diagnostics Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 STD Diagnostics Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global STD Diagnostics Market Size Growth Rate by Product
  • 1.4.2 Chlamydia Testing
  • 1.4.3 Syphilis Testing
  • 1.4.4 Gonorrhea Testing
  • 1.4.5 Herpes Simplex Virus Testing
  • 1.4.6 Human Papilloma Virus Testing
  • 1.4.7 Human Immunodeficiency Virus Testing
  • 1.4.8 Chancroid Testing
• 1.5 Market by End User
  • 1.5.1 Global STD Diagnostics Market Size Growth Rate by End User
  • 1.5.2 Laboratory Testing
  • 1.5.3 Point of Care Testing
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global STD Diagnostics Market Size
  • 2.1.1 Global STD Diagnostics Revenue 2014-2025
  • 2.1.2 Global STD Diagnostics Sales 2014-2025
• 2.2 STD Diagnostics Growth Rate by Regions
  • 2.2.1 Global STD Diagnostics Sales by Regions
  • 2.2.2 Global STD Diagnostics Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 STD Diagnostics Sales by Manufacturers
  • 3.1.1 STD Diagnostics Sales by Manufacturers
  • 3.1.2 STD Diagnostics Sales Market Share by Manufacturers
  • 3.1.3 Global STD Diagnostics Market Concentration Ratio (CR5 and HHI)
• 3.2 STD Diagnostics Revenue by Manufacturers
  • 3.2.1 STD Diagnostics Revenue by Manufacturers (2014-2019)
  • 3.2.2 STD Diagnostics Revenue Share by Manufacturers (2014-2019)
• 3.3 STD Diagnostics Price by Manufacturers
• 3.4 STD Diagnostics Manufacturing Base Distribution, Product Types
  • 3.4.1 STD Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers STD Diagnostics Product Type
  • 3.4.3 Date of International Manufacturers Enter into STD Diagnostics Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global STD Diagnostics Sales by Product
• 4.2 Global STD Diagnostics Revenue by Product
• 4.3 STD Diagnostics Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global STD Diagnostics Breakdown Data by End User

6 North America

• 6.1 North America STD Diagnostics by Countries
  • 6.1.1 North America STD Diagnostics Sales by Countries
  • 6.1.2 North America STD Diagnostics Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America STD Diagnostics by Product
• 6.3 North America STD Diagnostics by End User

7 Europe

• 7.1 Europe STD Diagnostics by Countries
  • 7.1.1 Europe STD Diagnostics Sales by Countries
  • 7.1.2 Europe STD Diagnostics Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe STD Diagnostics by Product
• 7.3 Europe STD Diagnostics by End User

8 Asia Pacific

• 8.1 Asia Pacific STD Diagnostics by Countries
  • 8.1.1 Asia Pacific STD Diagnostics Sales by Countries
  • 8.1.2 Asia Pacific STD Diagnostics Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific STD Diagnostics by Product
• 8.3 Asia Pacific STD Diagnostics by End User

9 Central & South America

• 9.1 Central & South America STD Diagnostics by Countries
  • 9.1.1 Central & South America STD Diagnostics Sales by Countries
  • 9.1.2 Central & South America STD Diagnostics Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America STD Diagnostics by Product
• 9.3 Central & South America STD Diagnostics by End User

10 Middle East and Africa

• 10.1 Middle East and Africa STD Diagnostics by Countries
  • 10.1.1 Middle East and Africa STD Diagnostics Sales by Countries
  • 10.1.2 Middle East and Africa STD Diagnostics Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa STD Diagnostics by Product
• 10.3 Middle East and Africa STD Diagnostics by End User

11 Company Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Abbott STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Abbott STD Diagnostics Products Offered
  • 11.1.5 Abbott Recent Development
• 11.2 ADI/American Diagnostica
  • 11.2.1 ADI/American Diagnostica Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 ADI/American Diagnostica STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 ADI/American Diagnostica STD Diagnostics Products Offered
  • 11.2.5 ADI/American Diagnostica Recent Development
• 11.3 Agilent Technologies
  • 11.3.1 Agilent Technologies Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Agilent Technologies STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Agilent Technologies STD Diagnostics Products Offered
  • 11.3.5 Agilent Technologies Recent Development
• 11.4 Alere/Biosite/Inverness
  • 11.4.1 Alere/Biosite/Inverness Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Alere/Biosite/Inverness STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Alere/Biosite/Inverness STD Diagnostics Products Offered
  • 11.4.5 Alere/Biosite/Inverness Recent Development
• 11.5 Axis-Shield
  • 11.5.1 Axis-Shield Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Axis-Shield STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Axis-Shield STD Diagnostics Products Offered
  • 11.5.5 Axis-Shield Recent Development
• 11.6 Beckman Coulter/Danaher
  • 11.6.1 Beckman Coulter/Danaher Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Beckman Coulter/Danaher STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Beckman Coulter/Danaher STD Diagnostics Products Offered
  • 11.6.5 Beckman Coulter/Danaher Recent Development
• 11.7 Becton Dickinson
  • 11.7.1 Becton Dickinson Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Becton Dickinson STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Becton Dickinson STD Diagnostics Products Offered
  • 11.7.5 Becton Dickinson Recent Development
• 11.8 Bio/Data
  • 11.8.1 Bio/Data Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bio/Data STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bio/Data STD Diagnostics Products Offered
  • 11.8.5 Bio/Data Recent Development
• 11.9 Decode Genetics
  • 11.9.1 Decode Genetics Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Decode Genetics STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Decode Genetics STD Diagnostics Products Offered
  • 11.9.5 Decode Genetics Recent Development
• 11.10 Diadexus
  • 11.10.1 Diadexus Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Diadexus STD Diagnostics Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Diadexus STD Diagnostics Products Offered
  • 11.10.5 Diadexus Recent Development
• 11.11 Diagnocure
• 11.12 Diagnostica Stago/Trinity Biotech
• 11.13 Diamedix
• 11.14 Polymedco
• 11.15 Qiagen
• 11.16 Roche
• 11.17 SDIX
• 11.18 Sequenom
• 11.19 Siemens
• 11.20 Sienco
• 11.21 Sysmex
• 11.22 Takara Bio
• 11.23 ThermoFisher
• 11.24 Tosoh
• 11.25 Wako
• 11.26 Zycare/Alere

12 Future Forecast

• 12.1 STD Diagnostics Market Forecast by Regions
  • 12.1.1 Global STD Diagnostics Sales Forecast by Regions 2019-2025
  • 12.1.2 Global STD Diagnostics Revenue Forecast by Regions 2019-2025
• 12.2 STD Diagnostics Market Forecast by Product
  • 12.2.1 Global STD Diagnostics Sales Forecast by Product 2019-2025
  • 12.2.2 Global STD Diagnostics Revenue Forecast by Product 2019-2025
• 12.3 STD Diagnostics Market Forecast by End User
• 12.4 North America STD Diagnostics Forecast
• 12.5 Europe STD Diagnostics Forecast
• 12.6 Asia Pacific STD Diagnostics Forecast
• 12.7 Central & South America STD Diagnostics Forecast
• 12.8 Middle East and Africa STD Diagnostics Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 STD Diagnostics Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details